Highlights Novartis AG London S.E.

Equities

0QM7

CH0038459415

Market Closed - London S.E. Other stock markets 11:59:30 2018-05-21 am EDT			5-day change	1st Jan Change
76.86 ^CHF	-1.00%		-0.77%	-.--%

Jun. 24	Foreign banks target Switzerland after UBS takeover of Credit Suisse	RE
Jun. 24	NOVARTIS AG : Barclays reaffirms its Sell rating	ZD

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Foreign banks target Switzerland after UBS takeover of Credit Suisse	Jun. 24	RE
Factbox-European companies cut jobs as economy sputters	Jun. 21	RE
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15	Jun. 20	DP
Novartis: towards the filing of a buyout offer for MorphoSys	Jun. 20	CF
MorphoSys Set to Delist Following Acquisition by Novartis	Jun. 20	MT
MorphoSys Inks Delisting Agreement After Takeover by Novartis	Jun. 20	MT
Biotech company Morphosys will soon disappear from the stock exchange	Jun. 20	RE
EU regulator mandates label updates on CAR-T cancer therapies	Jun. 14	RE
PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment	Jun. 14	MT
Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment	Jun. 13	CI
Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy	Jun. 07	MT
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	Jun. 07	MT
Novartis and others face Italy antitrust probe over eye drug	Jun. 06	RE
Three newcomers to the MDax - Rational, TUI and Traton move up	Jun. 06	RE
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout	Jun. 05	DJ
NOVARTIS : UBS reiterates buy recommendation after ASCO	Jun. 03	CF
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes	Jun. 02	RE
European Equities Close Higher in Friday Trading; Flash Euro Area Inflation Rises More Than Expected	May. 31	MT
Swiss Market Index in the Green Amid US Rate Cut Optimism	May. 31	MT
Novartis Says Late-Stage Scemblix Trial Meets Primary Endpoints	May. 31	MT